Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases
- PMID: 20183605
- PMCID: PMC2910114
- DOI: 10.1080/15257770903091904
Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases
Abstract
In addition to the already known differences between adenosine deaminase (ADA) and cytidine deaminase (CDA) in terms of their tertiary structure, the sphere of Zn(+2) coordination, and their reverse stereochemical preference, we present evidence that the enzymes also differ significantly in terms of the North/South conformational preferences for their substrates and the extent to which the lack of the O(4') oxygen affects the kinetics of the enzymatic deamination of carbocyclic substrates. The carbocyclic nucleoside substrates used in this study have either a flexible cyclopentane ring or a rigid bicyclo[3.1.0]hexane scaffold.
Figures
References
-
- Jones W, Kurz LC, Wolfenden R. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to the purine ribonucleoside, the enzyme’s affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site. Biochemistry. 1989;28:1242–1247. - PubMed
-
- Frick L, Yang C, Marquez VE, Wolfenden R. Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue of 3,4-dihydrouridine and the contribution of the 4-hydroxyl group to its binding affinity. Biochemistry. 1989;28:9423–9430. - PubMed
-
- Schroeder GK, Wolfenden R. Rates of spontaneous disintegration of DNA and the rate enhancements produced by DNA glycosylases and deaminases. Biochemistry. 2007;46:13638–13647. - PubMed
-
- Agarwal RP, Spector T, Parks RE. Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitors. Biochem. Pharmacol. 1979;26:259–267. - PubMed
-
- Glazer RI. Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression. Cancer Chemother. Pharmacol. 1980;4:227–235. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials